Protein phosphatase inhibitor calyculin – A modulates activation markers in TRAP-stimulated human platelets

References

• McEver RP, Martin MN. A monoclonal antibody to a membrane glycoprotein binds only to activated platelets. J Biol Chem 1984; 259: 9799–9804
   PubMed Web of Science ®Google Scholar
• Fox SC, May JA, Shah A, Neubert U, Heptinstall S. Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin. Platelets 2009; 20: 250–259
   PubMed Web of Science ®Google Scholar
• Kappelmayer J, Nagy B, Jr, Miszti-Blasius K, Hevessy Z, Setiadi H. The emerging value of P-selectin as a disease marker. Clin Chem Lab Med 2004; 42: 475–486
   PubMed Web of Science ®Google Scholar
• Tarnow I, Michelson AD, Barnard MR, Frelinger AL, 3rd, Aasted B, Jensen BR, Parving HH, Rossing P, Tarnow L. Neuropathy in type 1 diabetes mellitus is associated with increased circulating activated platelets and platelet hyperreactivity. Platelets 2009; 20: 513–519
   PubMed Web of Science ®Google Scholar
• Alberti S, Angeloni G, Tamburrelli C, Pampuch A, Izzi B, Messano L, Parisi Q, Santamaria M, Donati MB, de Gaetano G, et al. Platelet-leukocyte mixed conjugates in patients with arterial fibrillation. Platelets 2009; 20: 235–241
   PubMed Web of Science ®Google Scholar
• Israels SJ, McMillan-Ward EM. CD63 modulates spreading and tyrosine phosphorylation of platelets on immobilized fibrinogen. Thromb Haemost 2005; 93: 311–318
   PubMed Web of Science ®Google Scholar
• Nurden AT, Poujol C, Nurden P. Different activation states of GP IIb/IIIa complexes in platelets. Blood Coagul Fibrinol 1999; 10: S67–70
   PubMedGoogle Scholar
• Hourdille P, Heilmann E, Winckler J, Clemetson KJ, Nurden AT. Thrombin induces a rapid redistribution of glycoprotein Ib-IX complexes within the membrane systems of activated human platelets. Blood 1990; 76: 1503–1513
   PubMed Web of Science ®Google Scholar
• Berckmans RJ, Neiuwland R, Böing AN, Romijn FP, Hack CE, Sturk A. Cell-derived microparticles circulate in healthy humans and support low grade thrombin generation. Thromb Haemost 2001; 85: 639–646
   PubMed Web of Science ®Google Scholar
• Toth B, Nikolajek K, Rank A, Nieuwland R, Lohse P, Pihusch V, Friese K, Thaler CJ. Gender-specific and menstrual cycle dependent differences in circulating microparticles. Platelets 2007; 18: 515–521
   PubMed Web of Science ®Google Scholar
• Nieuwland R, Berckmans RJ, McGregor S, Böing AN, Romijn FP, Westendorp RG, Hack CE, Sturk A. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000; 95: 930–935
   PubMed Web of Science ®Google Scholar
• Bakouboula B, Morel O, Faure A, Zobairi F, Jesel L, Trinh A, Zupan M, Canuet M, Grunebaum L, Brunette A, et al. Procoagulant membrane microparticles correlate with the severity of pulmonary arterial hypertension. Am J Respir Crit Care Med 2008; 177: 536–544
   PubMed Web of Science ®Google Scholar
• Hoyt CH, Lerea KM. Aggregation-dependent signaling in human platelets is sensitive to protein serine/threonine phosphatase inhibitors. Biochemistry 1995; 34: 9565–9570
   PubMedGoogle Scholar
• Favre B, Turowski P, Hemmings BA. Differential inhibition and posttranslational modification of protein phosphatase 1 and 2A in MCF7 cells treated with calyculin-A, okadaic acid, and tautomycin. J Biol Chem 1997; 272: 13856–13863
   PubMed Web of Science ®Google Scholar
• Mitsuhashi S, Shima H, Tanuma N, Sasa S, Onoe K, Ubukata M, Kikuchi K. Protein phosphatase type 2A, PP2A, is involved in degradation of gp130. Mol Cell Biochem 2005; 269: 183–187
   PubMed Web of Science ®Google Scholar
• Mitsuhashi S, Shima H, Tanuma N, Matsuura N, Takekawa M, Urano T, Kataoka T, Ubukata M, Kikuchi K. Usage of tautomycetin, a novel inhibitor of protein phosphatase 1 (PP1), reveals that PP1 is a positive regulator of Raf-1 in vivo. J Biol Chem 2003; 278: 82–88
   PubMedGoogle Scholar
• Muranyi A, Erdodi F, Ito M, Gergely P, Hartshorn DJ. Identification and localization of myosin phosphatase in human platelets. Biochem J 1998; 330: 225–231
   PubMedGoogle Scholar
• Suzuki Y, Yamamoto M, Wada H, Ito M, Nakano T, Sasaki Y, Narumiya S, Shiku H, Nishikawa M. Agonist-induced regulation of myosin phosphatase activity in human platelets through activation of Rho-kinase. Blood 1999; 93: 3408–3417
   PubMedGoogle Scholar
• Kiss E, Muranyi A, Csortos C, Gergely P, Ito M, Hartshome DJ, Erdodi F. Integrin-linked kinase phosphorylates the myosin phosphatase target subunit at the inhibitory site in platelet cytoskeleton. Biochem J 2002; 365: 79–87
   PubMedGoogle Scholar
• Missy K, Plantavid M, Pacaud P, Viala C, Chap H, Payrastre B. Rho-kinase is involved in the sustained phosphorylation of myosin and the irreversible platelet aggregation induced by PAR1 activating peptide. Thromb Haemost 2001; 85: 514–520
   PubMedGoogle Scholar
• Erdodi F, Toth B, Hirano K, Hirano M, Hartshorne DJ, Gergely P. Endothall thioanhydride inhibits protein phosphatases-1 and -2A in vivo. Am J Physiol 1995; 269: C1176–1184
   PubMed Web of Science ®Google Scholar
• Dignat-George F, Freyssinet JM, Key NS. Centrifugation is a crucial step impacting microparticle measurement. Platelets 2009; 3: 225–226
   Google Scholar
• Nagy B, Jr, Szük T, Debreceni BI, Kappelmayer J. Platelet-derived microparticle levels are significantly elevated in patients treated by elective stenting compared to subjects with diagnostic catheterization alone. Platelets 2010; 21: 147–151
   PubMed Web of Science ®Google Scholar
• Losonczy G, Rosenberg N, Kiss C, Kappelmayer J, Vereb G, Kerenyi A, Balogh I, Muszbek L. A novel homozygous mutation (1619delC) in GPIIb gene associated with Glanzmann thrombasthenia, the decay of GPIIb-mRNA and the synthesis of a truncated GPIIb unable to form complex with GPIIIa. Thromb Haemost 2005; 93: 904–909
   PubMedGoogle Scholar
• Toyoda H, Nakai K, Omay SB, Shima H, Nagao M, Shiku H, Nishikawa M. Differential association of protein Ser/Thr phosphatase types 1 and 2A with the cytoskeleton upon platelet activation. Thromb Haemost 1996; 76: 1053–1062
   PubMedGoogle Scholar
• Yan Y, Mumby MC. Distinct roles for PP1 and PP2A in phosphorylation of the retinoblastoma protein. PP2a regulates the activities of G(1) cyclin-dependent kinases. J Biol Chem 1999; 274: 31917–31924
   PubMed Web of Science ®Google Scholar
• Lontay B, Kiss A, Gergely P, Hartshorne DJ, Erdodi F. Okadaic acid induces phosphorylation and translocation of myosin phosphatase target subunit 1 influencing myosin phosphorylation, stress fiber assembly and cell migration in HepG2 cells. Cell Signal 2005; 17: 1265–1275
   PubMed Web of Science ®Google Scholar
• Kiss A, Lontay B, Becsi B, Markasz L, Olah E, Gergely P, Erdodi F. Myosin phosphatase interacts with and dephosphorylates the retinoblastoma protein in THP-1 leukemic cells: Its inhibition is involved in the attenuation of daunorubicin-induced cell death by calyculin-A. Cell Signal 2008; 20: 2059–2070
   PubMed Web of Science ®Google Scholar
• Yano Y, Sakon M, Kambayashi J, Kawasaki T, Senda T, Tanaka K, Yamada F, Shibata N. Cytoskeletal reorganization of human platelets induced by the protein phosphatase 1/2 A inhibitors okadaic acid and calyculinA. Biochem J 1995; 307: 439–449
   PubMedGoogle Scholar
• Daniel JL, Molish IR, Rigmaiden M, Stewart G. Evidence for a role of myosin phosphorylation in the initiation of the platelet shape change response. J Biol Chem 1984; 259: 9826–9831
   PubMed Web of Science ®Google Scholar
• Paul BZ, Daniel JL, Kunapuli SP. Platelet shape change is mediated by both calcium-dependent and -independent signaling pathways. Role of p160 Rho-associated coiled-coil-containing protein kinase in platelet shape change. J Biol Chem 1999; 274: 28293–28300
   PubMed Web of Science ®Google Scholar
• Yano Y, Kambayashi J, Shiba E, Sakon M, Oiki E, Fukuda K, Kawasaki T, Mori T. The role of protein phosphorylation and cytoskeletal reorganization in microparticle formation from the platelet plasma membrane. Biochem J 1994; 299: 303–308
   PubMed Web of Science ®Google Scholar
• Watanabe Y, Ito M, Kataoka Y, Wada H, Koyama M, Feng J, Shiku H, Nishikawa M. Protein kinase C-catalyzed phosphorylation of an inhibitory phosphoprotein of myosin phosphatase is involved in human platelet secretion. Blood 2001; 97: 3798–3805
   PubMedGoogle Scholar
• Vijayan KV, Liu Y, Sun W, Ito M, Bray PF. The Pro33 isoform of integrin beta3 enhances outside-in signaling in human platelets by regulating the activation of serine/threonine phosphatases. J Biol Chem 2005; 280: 21756–21762
   PubMedGoogle Scholar
• Sakon M, Murata K, Fujitani K, Yano Y, Kambayashi J, Uemura Y, Kawasaki T, Shiba E, Mori T. Calyculin A inhibits the exposure of fibrinogen receptor in thrombin-stimulated platelets. Biochem Biophys Res Commun 1993; 195: 139–143
   PubMedGoogle Scholar
• Hamburger SA, McEver RP. GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood 1990; 75: 550–554
   PubMed Web of Science ®Google Scholar
• Minamino T, Kitakaze M, Sanada S, Asanuma H, Kurotobi T, Koretsune Y, Fukunami M, Kuzuya T, Hoki N, Hori M. Increased expression of P-selectin on platelets is a risk factor for silent cerebral infarction in patients with atrial fibrillation: Role of nitric oxide. Circulation 1998; 98: 1721–1727
   PubMed Web of Science ®Google Scholar
• Fujimoto T, McEver RP. The cytoplasmic domain of P-selectin is phosphorylated on serine and threonine residues. Blood 1993; 82: 1758–1766
   PubMedGoogle Scholar
• Smyth SS, McEver RP, Weyrich AS, Morrell CN, Hoffman MR, Arepally GM, French PA, Dauerman HL, Becker RC. 2009 Platelet Colloquium Participants. Platelet functions beyond hemostasis. J Thromb Haemost 2009; 7: 1759–1766
   PubMed Web of Science ®Google Scholar
• Blann A, Shantsila E, Shantsila A. Microparticles and arterial disease. Semin Thromb Hemost 2009; 35: 488–496
   PubMed Web of Science ®Google Scholar
• Sinauridze EI, Kireev DA, Popenko NY, Pichugin AV, Panteleev MA, Krymskaya OV, Ataullakhanov FI. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 2007; 97: 425–434
   PubMed Web of Science ®Google Scholar
• Maguire PB, Wynne KJ, Garney DF, O’Donoghue NM, Stephens G, Fitzgerald DJ. Identification of the phosphotyrosine proteome from thrombin activated platelets. Proteomics 2002; 2: 642–648
   PubMed Web of Science ®Google Scholar
• Szuk T, Nagy B, Jr, Bereczky Z, Koszegi Z, Edes I, Kappelmayer J. Effects of ad hoc clopidogrel loading versus pre-treatment on P-selectin expression after coronary stent implantation. Platelets 2006; 17: 344–346
   PubMed Web of Science ®Google Scholar